Brief: Ajanta Pharma Says No Form 483 Issued After FDA Inspection Of Dahej Facility
June 26 (Reuters) - Ajanta Pharma Ltd AJPH.NS :
* US FDA INSPECTION OF OUR DAHEJ FACILITY
* AT END OF INSPECTION, NO FORM 483 WAS ISSUED
Source text for Eikon: ID:nBSE1FfsT9
Further company coverage: AJPH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility